Table 1.
ARV detection | Viral suppression | |||||
---|---|---|---|---|---|---|
N tested | No. on ARV (%) | Adjusted PR (95% CI) | N tested | No. virally suppressed (%) | Adjusted PR (95% CI) | |
Sex | ||||||
Male | 131 | 69 (52.7) | Reference | 218 | 97 (44.5) | Reference |
Female | 185 | 102 (55.1) | 1.11 (0.91–1.37) | 310 | 159 (51.3) | 1.15 (.95–1.39) |
Unknown | 10 | 4 (40.0) | — | 14 | 7 (50.0) | — |
Age group, years | ||||||
0–19 | 11 | 3 (27.2) | 0.58 (0.22–1.54) | 33 | 19 (57.6) | 1.38 (0.95–2.01) |
20–29 | 73 | 37 (50.7) | Reference | 113 | 45 (39.8) | Reference |
30–39 | 101 | 59 (58.4) | 1.17 (0.88–1.55) | 167 | 82 (49.1) | 1.20 (0.91–1.58) |
40–49 | 72 | 47 (65.3) | 1.31 (0.98–1.76) | 112 | 62 (55.4) | 1.37 (1.04–1.82)* |
≥50 | 55 | 25 (45.5) | 0.92 (0.63–1.33) | 95 | 42 (44.2) | 1.11 (0.81–1.53) |
Unknown | 14 | 4 (28.6) | — | 22 | 13 (59.1) | — |
Total | 326 | 175 (53.5) | 542 | 263 (48.5) |
Multivariable log-binomial model for each outcome was adjusted for sex and age group. Individuals with missing data on sex and age group were excluded from the model.
p < .05.
ARV, antiretroviral; CI, confidence interval; PR, prevalence ratio.